Applied Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Applied Therapeutics, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $10.24 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2025-11-13
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $10.24M.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2025-09-30 | $10.24M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 |
| 2024-12-31 | $0.00 10-K · filed 2025-04-15 |
| 2024-09-30 | $26.56M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $10.47M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $20.64M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $7.04M 10-K · filed 2024-03-06 |
| 2023-09-30 | $4.19M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $558.00K 10-Q · filed 2023-08-10 |
| 2022-03-31 | $489.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $10.26M 10-K · filed 2022-03-10 |
| 2021-09-30 | $28.63M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $39.66M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $35.08M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $36.90M 10-K · filed 2021-03-18 |
| 2020-09-30 | $33.86M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $67.49M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $61.12M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $34.82M 10-K · filed 2020-03-13 |
| 2019-09-30 | $11.17M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $7.60M 10-Q · filed 2019-08-12 |